🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of our research will be to determine the effectiveness of 17 alpha...
Status
Withdrawn
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00120640
Treatments Being Tested
To demonstrate that Makena® (Hydroxyprogesterone Caproate Injection, 250 mg...
Status
Terminated
Location
Lotus Clinical Research, LLC
Start Date
2016-10-07
Trial ID
NCT02937766
To demonstrate that the intramuscular administration of 17 alpha hydroxypro...
Status
Completed
Location
CHI Poissy st Germain
Start Date
2006-06
Trial ID
NCT00331695
Treatments Being Tested
Hypothesis: Among women with twin or triplet pregnancies, weekly injections...
Status
Completed
Location
Banner Good Samaritan Hospital
Start Date
2004-11
Trial ID
NCT00163020
Treatments Being Tested
Emergency data suggest 17OHP-C may be less efficacious in obese women. Sinc...
Status
Completed
Location
University of South Florida
Start Date
2017-08-23
Trial ID
NCT03433040
Treatments Being Tested
Purpose to evaluate the effects of intramuscular 17-Alpha-Hydroxyprogestero...
Status
Unknown
Location
Aswan University
Start Date
2019-01-01
Trial ID
NCT03779438
Treatments Being Tested
Preterm birth remains a major cause of perinatal morbidity and mortality in...
Status
Completed
Location
American University of Beirut
Start Date
2006-10
Trial ID
NCT00141908
Treatments Being Tested
A recently completed trial of weekly injections of 17 alpha hydroxyprogeste...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2005-02
Trial ID
NCT00135902
We hypothesized that weekly intramuscular injections of 17 hydroxyprogester...
Status
Terminated
Location
Lehigh Valley Hospital
Start Date
2003-11
Trial ID
NCT00694967
Treatments Being Tested
Gonadotropin Releasing Hormone agonist (GnRHa) triggering is used as an alt...
Status
Unknown
Location
Shamir Medical center
Start Date
2017-12-29
Trial ID
NCT04797338
Treatments Being Tested